NVentures

Activity from announced rounds

All recorded activity

NVentures is NVIDIA’s venture capital arm, investing in AI infrastructure, robotics, digital biology, applied AI and frontier computing.

Its portfolio relationships include access to NVIDIA technical teams, product integrations and go-to-market support. This can involve embedding technologies such as Nemotron or BioNeMo into a startup’s products and working with NVIDIA’s broader commercial ecosystem.

The technical collaboration is visible in robotics companies using Isaac Lab and Cosmos for simulation and model development. NVentures’ investment relationship is distinct from Inception, NVIDIA’s free programme for startup technical resources, discounts and cloud credits.

Sources
Rounds participated in
22
Confirmed lead rounds
0
15 roles undisclosed
New companies
22
First participation on record · 0 follow-on
Funding in participating rounds
$6.2B
19 disclosed · full round size, not this investor’s share

By stage

Series C+8
Series B7
Undisclosed4
Seed2
Series A1

By primary sector

AI7
Hardware4
Climate tech2
Healthtech2
Mobility2
5 more
Biotech1
Cybersecurity1
Enterprise software1
Industrial tech1
Proptech1

By country

United States15
United Kingdom4
Canada1
France1
Sweden1

Rounds

22 in all activity
Emulate AI

Emulate AI is a British artificial intelligence research company developing world models.

UndisclosedReported strategic investment
Participant
Orbital Industries

Orbital Industries uses AI to develop materials and industrial hardware.

$50MSeries B
Participant
Tensormesh

Optimizes AI inference costs for enterprises via KV caching to eliminate redundant GPU computation

$20MSeed+
Role not disclosed
OpenRouter

Provides a unified API gateway enabling access, routing, and optimization across 400+ AI models for developers and enterprises

$113MSeries B
Role not disclosed
Alice & Bob

Alice & Bob develops quantum computing hardware and software around cat qubits, aiming to build a universal, fault-tolerant computer.

UndisclosedSeries B extension
Role not disclosed
XBOW

Runs autonomous AI agents that continuously probe software for vulnerabilities at machine speed

$35MSeries C+
Role not disclosed
RadixArk

Builds open-source AI inference and training infrastructure, commercializing the SGLang engine

$100MSeed
Role not disclosed
Legora

Legora develops AI software for law firms and in-house legal teams.

$100MSeries D+
Role not disclosed
Aidoc

Aidoc provides clinical AI software that helps hospitals analyze imaging, prioritize findings and coordinate follow-up care.

$150MSeries E
Role not disclosed
Oxa

Develops configurable autonomous driving software for industrial environments

$103MSeries D
Role not disclosed
Freeform

Develops AI-native 3D-printing systems for metal components using real-time simulations

$67MSeries B
Role not disclosed
Bedrock Robotics

Develops autonomous construction technology for general contractors

$270MSeries B
Role not disclosed
Waabi

Waabi develops AI-powered autonomous driving technology for trucking.

$750MSeries C
Participant
Redwood Materials

Recycles batteries and produces cathode materials for energy storage

$425MSeries E
Role not disclosed
Ricursive Intelligence

Builds a next-generation platform that closes the recursive feedback loop between AI models and t...

$300MSeries A
Role not disclosed
Synthesia

Develops AI-powered digital avatars for corporate clients

$200MSeries E
Role not disclosed
Skild AI

Building a unified robotics foundation model for controlling robots

$1.4BUndisclosed
Role not disclosed
Proxima

Develops AI-driven drug discovery for proximity therapeutics

$80MUndisclosed
Role not disclosed
PsiQuantum

PsiQuantum develops photonic quantum computing systems designed for fault-tolerant, utility-scale operation.

$1BSeries E
Participant
Quantinuum

Quantinuum develops quantum computers and software for researchers and organizations building quantum applications.

~$600MEquity capital raise
Participant
Hippocratic AI

Hippocratic AI develops patient-facing conversational AI agents for healthcare organizations.

$141MSeries B
Participant